SYS-CON MEDIA Authors: Kevin Benedict, Jason Bloomberg, David H Deans, RealWire News Distribution, Gilad Parann-Nissany

News Feed Item

Global Biomaterials Market

DUBLIN, March 5, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/2rhwnh/global) has announced the addition of the "Global Biomaterials Market" report to their offering. 


     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

There has been steady innovation in the Global Biomaterials market with several players increasing R&D expenditure every year. For instance, the use of carbon fiber in conjunction with biomaterials for the manufacture of composite materials is being explored. While innovation is imperative in an industry such as this where competition is rampant, the need for novel solutions to cater to patient needs in the Medical industry is also expected to lead to innovation in the market. 

Biomaterials were traditionally used for repair and replacement of body tissues. However, there has been an increasing focus on the provision of biomaterials for self-healing in patients. Thus, the Global Biomaterials market is expected to witness innovation.
According to the report, one of the main drivers is the increase in the aging population. 

The number of people aged 60 or over is expected to double in the next 50 years, thereby resulting in increased demand for healthcare services because of increasing physical disabilities. Further, the report states that one of the main challenges in the Global Biomaterials market is the stringent regulations in some countries such as the US regarding the production of biomaterials. As a result of various certification norms, vendors are facing a challenge in terms of the time to market of their product.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. 


Key Topics Covered: 

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology

5. Scope of the Report

6. Market Landscape

7. Market Segmentation by Type

8. Market Segmentation by Therapeutic Use

9. Market Segmentation by Application

10. Geographical Segmentation

11. Vendor Landscape

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Key Vendor Analysis

19. Other Reports in this Series


Companies Mentioned:

  • AdvanSource Biomaterials Corp.
  • Allergan Inc.
  • Alphatec Spine Inc.
  • Amedica Corp.
  • Angiotech Pharmaceuticals Inc.
  • Basf SE
  • Bayer AG
  • Berkeley Advanced Biomaterials Inc.
  • BioSyntech Inc.
  • Biocomposites Ltd.
  • Biomet Inc.
  • Cam Bioceramics BV
  • Carpenter Technology Corp.
  • Ceradyne Inc.
  • Ceramtec Collagen Matrix Inc.
  • CollPlant Holdings Ltd.
  • Covalon Technologies Ltd.
  • CryoLife Inc.
  • Dentsply International Inc.
  • Depuy Orthopaedics Inc.
  • Dsm Biomedical Inc.
  • ETEX Corp.
  • Evonik Industries AG
  • Exactech Inc.
  • Heraeus Medical Components Inc.
  • Hycail Finland OY
  • Integra LifeSciences Holdings Corp.
  • Invibio Ltd.
  • Kyocera Corp.
  • Landec Corp.
  • Materion Corp.
  • Medtronic Inc.
  • Morgan Technical Ceramics
  • Orthovita Inc.
  • Osteotech Inc.
  • Purac Biomaterials
  • RTI Biologics Inc.
  • Sigma-Aldrich Corp.
  • Starch Medical Inc.
  • Stryker Corp.
  • Ticona GmbH
  • Ulbrich Stainless Steels & Special Metals Inc.
  • Zimmer Holdings Inc.
  • and Wright Medical Group Inc.; 3DM Inc.


For more information visit http://www.researchandmarkets.com/research/2rhwnh/global


Media Contact: Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.